EntryPoint Capital »

Ultragenyx Pharmaceutical shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $547k 26k 20.95
2025-09-30 $345k 12k 30.08
2025-06-30 $385k 11k 36.36
2025-03-31 $398k 11k 36.21
2024-12-31 $292k 6.9k 42.07
2024-06-30 $104k 2.5k 41.10